Semaglutide TFA, a long-acting GLP-1 analogue, is a glucagon-like peptide-1 (GLP-1) receptor agonist. Semaglutide TFA has the potential for type 2 diabetes treatment.
| Molecular Weight | 4227.66 |
| Solubility (25°C) | Water 90 mg/mL |
| Storage | -20°C, dry, sealed |
| Species | Mouse | Rat | Rabbit | Guinea pig | Hamster | Dog |
| Weight (kg) | 0.02 | 0.15 | 1.8 | 0.4 | 0.08 | 10 |
| Body Surface Area (m2) | 0.007 | 0.025 | 0.15 | 0.05 | 0.02 | 0.5 |
| Km factor | 3 | 6 | 12 | 8 | 5 | 20 |
| Animal A (mg/kg) = Animal B (mg/kg) multiplied by | Animal B Km |
| Animal A Km |
For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.
| Related Glucagon Receptor Products |
|---|
| AZD9550
AZD9550 is a GLP-1R/GCGR dual agonist that may be used in studies related to non-alcoholic steatohepatitis (NASH). |
| K-833
K-833 is a GLP-1R modulator that can be used in studies related to type 2 diabetes and obesity. |
| CT-996
CT-996 is a GLP-1R agonist that can be used in studies related to type 2 diabetes and obesity. |
| RGT-075
RGT-075 is a GLP-1R modulator that can be used in studies related to metabolic diseases as well as type 2 diabetes. |
| GSBR-1290
GSBR-1290 is a GLP-1R agonist that can be used in studies related to type 2 diabetes and obesity. |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.
